Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Lancet Oncol. 2013 Feb;14(2):134–140. doi: 10.1016/S1470-2045(12)70572-7

TABLE 3.

Response Rate and Progression Free Survival

Characteristic Category No. of Cases % of Cases
Response Complete Response 1 1.9
Partial Response 7 13.5
Stable Disease 34 65.4
Increasing Disease 8 15.4
Indeterminate 2 3.8
Cycles of Treatment 1 7 13.5
2 8 15.4
3 6 11.5
4 5 9.6
5 1 1.9
6 2 3.8
7 2 3.8
10 4 7.7
12 2 3.8
13 1 1.9
14 3 5.8
15 2 3.8
>15 9 17.3
Alive Without progression 10 19.2
With progression 22 42.3
Dead From disease 17 32.7
From neither Rx nor disease 1 1.9
From undetermined cause 1 1.9
Pending 1 1.9

Three patients remain on study therapy (after receiving 20, 33, and 35 cycles).

As of database lock, May 16, 2011.